Nano-X Imaging (NNOX) Cash & Equivalents (2019 - 2026)

Nano-X Imaging (NNOX) has reported Cash & Equivalents for 8 consecutive years, with $43.9 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 8.62% year-over-year to $43.9 million; the trailing twelve-month figure through Mar 2026 stood at $43.9 million (up 8.62% YoY), and the FY2025 full-year result was $49.2 million, up 25.05% from the prior year.
• Cash & Equivalents declined to $43.9 million in Q1 2026 per NNOX's latest filing, from $49.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $40.3 billion in Q3 2022 and bottomed at $38.2 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $2.4 billion across 5 years, with a median of $44.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 18765.3% in 2022, then tumbled 99.83% in 2023.
• Over 5 years, Cash & Equivalents stood at $38.5 million in 2022, then surged by 46.32% to $56.4 million in 2023, then tumbled by 30.28% to $39.3 million in 2024, then rose by 25.05% to $49.2 million in 2025, then retreated by 10.77% to $43.9 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $43.9 million, $49.2 million, and $45.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.